Exchange: NYSE·Updated 04:39 PM EDT
News
all
press releases
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners PR Newswire LAVAL, QC, Aug. 27, 2026 This year's Aspire Higher scholarships are awarded to six students who have been...
PR Newswire
More News
Can Bausch (BHC) Run Higher on Rising Earnings Estimates?
Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
Bausch (BHC) Upgraded to Buy: Here's What You Should Know
Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners PR Newswire LAVAL, QC, Aug. 17, 2026 For the Seventh Consecutive Year, 10 Students with Gastrointestinal DiseaseWill Each Receive a $10,000...
PR Newswire
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month
Key PointsInvestors were cheered by the beat-and-raise second quarter...
Nasdaq News: Markets
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board PR Newswire LAVAL, QC, Aug. 6, 2026 LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company"),today announced...
PR Newswire
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue and EBITDA guidance after strong earnings.
Zacks
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
Bausch (BHC) delivered earnings and revenue surprises of +31.25% and +7.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks

Advertisement|Remove ads.